bpc-157 delayed onset muscle soreness – No Proof Required! | Office for Science and Society Is Intra-Articular Administration of BPC
Description
KPV: Generally well-tolerated
Typical protocol: Dose: 0.51.5 mg subcutaneously 23x/week Often cycled: 4 weeks on, 2 weeks off Multi-Peptide Blends: KLOW and GLOW Pre-mixed peptide blends like KLOW combine BPC-157, TB-500, and GHK-Cu in a single vial
Your health provider can guide you to safer ways to maintain health and fitness that dont involve off-label use of potent peptides
Continuous exposure to stomach acid can cause inflammation and damage to the esophageal lining, leading to discomfort and pain
